Photo Release: Faculty of Medicine, Chiang Mai University and Modernine TV

Food and Healthcare Press Releases Tuesday November 30, 2010 16:42
Bangkok--30 Nov--Core & Peak
Faculty of Medicine, Chiang Mai University and Modernine TV jointly host Healthy Avenue event.

Recently, Mr.Pornchai Piyakesin, MCOT's acting Assistance Director-General for the TV Broadcasting Department, MCOT Public Company Limited. (2nd from left), Assistant Professor Niwet Nantajit, M.D., Dean of Faculty of Medicine, Chiang Mai University (3rd from left) and Mr.Richard Abela, Country President of Novartis (Thailand) Limited (1st from left), one of the leading pharmaceutical business companies, presided the opening ceremony of “Healthy Avenue….Thanon Ruamphon Khon Rak Sukkhaphap” event at Broadcasting Operation Building, MCOT Public Company Limited. This event provided free medical examination and consultation by doctors from Maharaj Nakorn Chiang Mai Hospital (Suan Dok). There is also a talk to provide knowledge on how to prevent harmful diseases such as blood pressure, Osteoporosis and Diabetes, etc. This event was well-attended by MCOT employees.

Press Contact:
Khun Siriporn Sirinitsriwong and Khun Srisuput Siangyen
PR Consultant, Core & Peak Co., Ltd.
Tel. 0-2439-4600 Ext. 8300
Email: siriporns@corepeak.com, srisuput@corepeak.com

Latest Press Release

Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease

-- Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol -- Mallinckrodt plc (NYSE:MNK), a leading global specialty pharmaceutical company, today announced...

Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community shorten the diagnostic odyssey

- Global Commission's recommendations focus on three solution pathways that leverage technology to address key elements of the rare disease diagnostic odyssey - Rare diseases remain undiagnosed as patients struggle to navigate complex health systems to...

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net)...

Related Topics